Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04092673
Title Study of eFT226 in Subjects With Selected Advanced Solid Tumor Malignancies
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Effector Therapeutics
Indications

Advanced Solid Tumor

pancreatic adenocarcinoma

Therapies

eFT226

Age Groups: senior | adult
Covered Countries USA

Additional content available in CKB BOOST